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Background
Neurotrophin-3 (NT-3) is produced by astrocytes, in addi-
tion to neurons, and monoamine neurotransmitters play
a role in controlling NT-3 synthesis [1]. The impact of his-
tamine on the regulation of NT-3 synthesis in cultured
astrocytes has not been studied in detail. Therefore, we
focused our present study on the active involvement of
multiple histaminergic receptor and intracellular mecha-
nisms in the regulation of NT-3 production by histamine.
Results
Histamine (1 μM) significantly and transiently elevates
NT-3 mRNA levels by 2.2-fold after 30 min of incubation
following by 2.1-fold increase in NT-3 intracellular levels
after 6 h. Its stimulation was partly inhibited by the H1
antagonists triprolidine and mepyramine, the H2 antago-
nists famotidin and cimetidin, and by the H3 antagonist
ciproxifan. NT-3 levels in astrocytes were increased by spe-
cific and selective H1, H2 and H3 agonists, but none of the
tested agonists was able to reach the level of histamine's
stimulatory effect. Different activators of basic intracellu-
lar histamine receptor second messenger systems (forsko-
lin, dibutyryl cAMP, dBcAMP; as well as calcimycin, i.e.
Ca2+ ionophore A23187) and phorbol 12-myristate 13-
acetate, TPA) markedly increase the cellular level of NT-3
protein. Histamine-induced cellular levels of NT-3 were
significantly reduced by H-89 (an inhibitor of protein
kinase A, PKA) and by staurosporin (an inhibitor of pro-
tein kinase C, PKC). Studying histamine receptor subtype
expression in astrocytes using quantitative RT-PCR we
confirmed that the expression levels of histamine H1 and
H2 receptors (already shown in radioligand binding) as
well as of H3 receptors are high.
Conclusion
Our study confirmed that the synthesis of NT-3 in astro-
cytes is regulated by the histaminergic system and indicate
the possible involvement of multiple, complex histamine
H1, H2 and H3 receptors and corresponding intracellular
mechanisms involving the cAMP/PKA pathway, as well as
mobilisation of Ca2+ ions and activation of PKC.
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